Literature DB >> 9082587

[The efficacy of pamidronate in reducing skeletal associated events in patients with advanced multiple myeloma].

I A Adamietz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9082587     DOI： 10.1007/bf03039196

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  2 in total

1.  Palliative radiotherapy in plasma cell myeloma.

Authors:  I A Adamietz; C Schöber; R W Schulte; D Peest; K Renner
Journal:  Radiother Oncol       Date:  1991-02       Impact factor: 6.280

2.  Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

Authors:  J R Berenson; A Lichtenstein; L Porter; M A Dimopoulos; R Bordoni; S George; A Lipton; A Keller; O Ballester; M J Kovacs; H A Blacklock; R Bell; J Simeone; D J Reitsma; M Heffernan; J Seaman; R D Knight
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245
  2 in total
  1 in total

Review 1.  Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies.

Authors:  Vassilios Vassiliou; Nikolaos Tselis; Dimitrios Kardamakis
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.